When will Dexamethasone Sodium Phosphate Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Dexamethasone Sodium Phosphate Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Dexamethasone Sodium Phosphate Injection

Brand names: Dexamethasone Sodium Phosphate

Category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology

Limited 2Available 17

FDA status: Current · Last FDA update: Sep 18, 2026 · First posted: Feb 8, 2019 (in shortage 7 years 7 months) · 5 manufacturers, 19 listed presentations

As of Sep 18, 2026, the FDA lists Dexamethasone Sodium Phosphate Injection as currently in shortage. Of 19 manufacturer presentations, 2 Limited, 17 Available.

Ask your pharmacist: which of the 5 manufacturers below can they order right now, and whether a different strength or form of Dexamethasone Sodium Phosphate Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10) NDC 76045-210-10	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01) NDC 63323-165-01	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30) NDC 63323-165-30	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05) NDC 63323-165-05	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10) NDC 76045-0210-10	Fresenius Kabi USA, LLC	Available	Checkwholesalers for inventory
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25) NDC 0641-6146-25	Hikma Pharmaceuticals USA, Inc.	Available	Additional product will be made available as it is released.
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25) NDC 0641-6145-25	Hikma Pharmaceuticals USA, Inc.	Available	Additional product will be made available as it is released.
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54) NDC 67457-422-54	Mylan Institutional, a Viatris Company	Available	-
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30) NDC 67457-421-30	Mylan Institutional, a Viatris Company	Available	-
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12) NDC 67457-423-12	Mylan Institutional, a Viatris Company	Available	-
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10) NDC 76045-0212-10	Fresenius Kabi USA, LLC	Limited	3 month expiry available on request. Next release not available at this time.
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10) NDC 76045-212-10	Fresenius Kabi USA, LLC	Limited	3 month expiry available on request. Next release not available at this time.
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25) NDC 55150-304-25	Eugia US LLC	Available	Check wholesalers for inventory
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10) NDC 63323-516-10	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01) NDC 63323-506-01	Fresenius Kabi USA, LLC	Available	Check wholesalers for inventory
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25) NDC 0641-0367-25	Hikma Pharmaceuticals USA, Inc.	Available	Product will be made available as it is released.
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10) NDC 67457-420-10	Mylan Institutional, a Viatris Company	Available	-
Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25) NDC 70069-021-25	Somerset Therapeutics, LLC	Available	-
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10) NDC 70069-025-10	Somerset Therapeutics, LLC	Available	-

Related medications in shortage

Other Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Dexamethasone Sodium Phosphate Injection (FDA data as of Sep 18, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Dexamethasone Sodium Phosphate Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Dexamethasone Sodium Phosphate Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/dexamethasone-sodium-phosphate-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).